|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.100 EUR | +0.92% |
|
0.00% | -25.17% |
| 04/06 | Equities trend higher; banks lead gains on the MIB | AN |
| 22/05 | European markets rebound; STM and Stellantis lead gains | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 55 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 55 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.92% | 0.00% | -8.71% | -6.78% | 10.7M | ||
| -1.43% | +1.32% | +41.17% | +157.42% | 1,035B | ||
| +0.49% | +3.08% | +53.17% | +50.06% | 574B | ||
| +0.12% | -0.94% | +16.98% | +63.43% | 397B | ||
| +0.58% | +0.77% | +21.19% | +15.95% | 324B | ||
| -0.85% | -2.86% | +22.05% | +13.80% | 281B | ||
| +0.44% | +3.48% | +24.48% | +34.39% | 278B | ||
| +1.66% | +5.61% | -44.67% | -47.49% | 193B | ||
| -0.07% | +1.48% | +19.33% | +63.21% | 191B | ||
| -1.01% | -3.42% | +11.33% | +60.21% | 156B | ||
| Average | +0.12% | +1.07% | +15.63% | +40.42% | 342.99B | |
| Weighted average by Cap. | -0.23% | +2.39% | +28.16% | +72.25% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















